Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enters Offshore Arena with Global Energy Major

11 Oct 2010 07:00

RNS Number : 1413U
ViaLogy PLC
11 October 2010
 



 

ViaLogy Plc ("ViaLogy")

ViaLogy Enters Offshore Arena with Global Energy Major

Aims to demonstrate major improvements over conventional seismic analysis in deepwater and onshore

London, October 11, 2010. ViaLogy PLC (VIY) announces it has been engaged by a second global energy company for QuantumRD performance assessment projects. The analysis targets large oilfields outside the United States. Following the recent announcement of a supermajor contract, ViaLogy has been approached by several US and non-US companies for de-risking both onshore and offshore prospects.

Under the performance assessments, ViaLogy will use its proprietary quantum seismic interferometry technology, QuantumRD, to delineate productive formations in a deepwater reservoir for a large offshore development prospect. De-risking such prospects typically relies on drilling multiple, costly test wells because of the inability of conventional 3-D seismic analysis to image fluids. The offshore project requires that ViaLogy predict oil and/or gas bearing zones from 3D seismic data in a complex sandstone reservoir setting. Sandstone reservoirs are common across the globe and can be highly productive, depending upon the accuracy of mapping interlaced sediment within reservoir or basin-scale geometry to delineate source, seal and reservoir geologies. The value-add of QuantumRD is its ability to increase resolution of the seismic data to assess hydrocarbon presence and fluid saturation. The business value of being able to map subsurface saturation patterns is the potential to maximize extraction and production, and to avoid costs normally associated with locating hydrocarbons.

The client commissioning the work is a Fortune Global 500 company.

QuantumRD will also be used to determine the attributes of a major onshore formation for the client. The onshore application leverages QuantumRD's demonstrated ability to discover subtle channel sands in complex stratigraphies. ViaLogy intends to delineate and size production grade hydrocarbon-bearing depositions in an onshore reservoir that spans several hundred square miles.

These prospects have been previously analyzed by the some of the leading geophysical services providers. Both the client and the locations of the projects remain confidential.

ViaLogy has positioned QuantumRD to provide services on a global basis for a broad class of sandstone, carbonate and shale gas reservoirs to characterize formation porosity, lithology and map hydrocarbon presence. This follows two years of development and testing in onshore US prospects where QuantumRD successfully positioned multiple wells and, retrospectively, correctly explained the outcome of over 250 more wells.

ViaLogy CEO Robert W. Dean said, "These technology assessment projects are a major step forward for us, providing the opportunity to work in very large fields, showing the technology's capability offshore, and demonstrating its enormous commercial potential. In both of these offshore and onshore prospects currently available conventional seismic analysis technologies have thus far been unsuccessful."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMMMGDGFGGZM
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.